Research conducted under the five-year CRADA could lead to the development of a new blood test that predicts patients at risk for heart disease and metabolic syndrome. The collaboration could also lead to the development of new targeted drugs.
If the drug reaches the market, likely through a partnership with a pharma, UC Davis stands to receive a "modest" royalty based on sales of the drug as part of an exclusive licensing agreement it signed with Arete.
Shamil Sunyaev, an assistant professor of medicine at Harvard Medical School, has been studying how resequencing all human exons could help discover genes related to human traits. He spoke with In Sequence this week.
Georgia Biotech Tort-Shield Bill, Michigan 'Cluster of Innovation,' Maryland Nanobiotechnology Grants, North Carolina Biotechnology Center, Solano Economic Development Corp., Hong Kong Stimulus Package
Though the budget would raise by one-third, or to $20 million, the state's maximum annual outlay to life-sci center grants covered by the Commonwealth Life Sciences Investment Program, it still falls short of the $25 million annual limit set by the Massachusetts Life Sciences Act.